stefan magez

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (22)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (17)

Wim Versées

Vrije Universiteit Brussel

BELGIUM

View details

ZENG LI

Vrije Universiteit Brussel

BELGIUM

View details

Wesley De Neve

Ghent University

BELGIUM

View details

Alexander Volkov

Vrije Universiteit Brussel

BELGIUM

View details

Cécile Vincke

Vrije Universiteit Brussel

BELGIUM

View details

Marc Desquesnes

Université de Montpellier

FRANCE

View details

Hyunbum Jeon

Chief Researcher

SOUTH KOREA

View details

Jo Van Ginderachter

Vrije Universiteit Brussel

BELGIUM

View details

Kim Roelants

Vrije Universiteit Brussel

BELGIUM

View details

Peter Tompa

Vrije Universiteit Brussel

BELGIUM

View details

Carl De Trez

Vrije Universiteit Brussel

BELGIUM

View details

Han Remaut

Vrije Universiteit Brussel

BELGIUM

View details

Steve Schoonooghe

Vrije Universiteit Brussel

BELGIUM

View details

Benoit Stijlemans

Vrije Universiteit Brussel

BELGIUM

View details

Inge Van Molle

Vrije Universiteit Brussel

BELGIUM

View details

Yann Sterckx

Professor

University of Antwerp

BELGIUM

View details

ANDRES ALVAREZ RODRIGUEZ

Vrije Universiteit Brussel

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

stefan magez

Research Interests

Explore related searches

Contact this professor

Articles (22)

Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody

A CRISPR-Cas-based recombinase polymerase amplification assay for ultra-sensitive detection of active Trypanosoma brucei evansi infections

Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids

Beyond the VSG layer: Exploring the role of intrinsic disorder in the invariant surface glycoproteins of African trypanosomes.

Effect of Leishmania infantum infection on B cell lymphopoiesis and memory in the bone marrow and spleen

Advances in the Immunology of the Host–Parasite Interactions in African Trypanosomosis, including Single-Cell Transcriptomics

Recent Progress in the Detection of Surra, a Neglected Disease Caused by Trypanosoma evansi with a One Health Impact in Large Parts of the Tropic and Sub-Tropic World

A Nanobody/Monoclonal Antibody "hybrid" sandwich technology offers an improved immunoassay strategy for detection of African trypanosome infections

Advances in the Immunology of the Host–Parasite Interactions in African Trypanosomosis, including Single-Cell Transcriptomics

Nanobodies: A Review of Generation, Diagnostics and Therapeutics

Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challenge

Biophysical characterization of the Plasmodium falciparum circumsporozoite protein's N-terminal domain.

Neutrophil metalloproteinase driven spleen damage hampers infection control of trypanosomiasis

Tryp

Detrimental Effect of Trypanosoma brucei brucei Infection on Memory B Cells and Host Ability to Recall Protective B-cell Responses

The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections

Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021

Tipping the balance between erythroid cell differentiation and induction of anemia in response to the inflammatory pathology associated with chronic trypanosome infections

Recent progress in diagnosis and treatment of Human African Trypanosomiasis has made the elimination of this disease a realistic target by 2030

The COMBAT project: controlling and progressively minimizing the burden of vector-borne animal trypanosomosis in Africa

Single-cell transcriptome profiling and the use of AID deficient mice reveal that B cell activation combined with antibody class switch recombination and somatic hypermutation do not benefit the control of experimental trypanosomosis

Improving the yield of recalcitrant Nanobodies® by simple modifications to the standard protocol

Collaborators (17)

Wim Versées

ZENG LI

Wesley De Neve

Alexander Volkov

Cécile Vincke

Marc Desquesnes

Hyunbum Jeon

Jo Van Ginderachter

Kim Roelants

Peter Tompa

Carl De Trez

Han Remaut

Steve Schoonooghe

Benoit Stijlemans

Inge Van Molle

Yann Sterckx

ANDRES ALVAREZ RODRIGUEZ

Make your next move.